In this episode of Denatured, you'll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a life sciences-only angel group matters, how they evaluate opportunities, and the importance of strong teams, capital efficiency and a realistic path to exit.HostJennifer C. Smith-Parker, Director of Insights, BioSpaceGuestsYaniv Sneor, Founder, Mid Atlantic Bio AngelsAlex Pederson, Investor, Mid Atlantic Bio Angels & Partner, Alloy Bio ConsultingDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Q1 earnings take off, Lilly strikes deals, Regeneron notches historic approval, FDA raises questions
The next era of diabetes management
Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
Funding the Future of European Biotech
Free AI-powered recaps of BioSpace and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.